These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18727742)

  • 1. Intention-to-treat has implications for study planning and execution, not just subject retention and follow-up.
    Hodges JS
    J Clin Periodontol; 2008 Aug; 35(8):683-4. PubMed ID: 18727742
    [No Abstract]   [Full Text] [Related]  

  • 2. ITT in respect to GCP: a matter of diligence.
    Van der Weijden F; Slot DE; Rosema M; Timmerman M
    J Clin Periodontol; 2008 Aug; 35(8):681-2. PubMed ID: 18727741
    [No Abstract]   [Full Text] [Related]  

  • 3. Intention-to-treat analysis: protecting the integrity of randomization.
    Mahaniah KJ; Rao G
    J Fam Pract; 2004 Aug; 53(8):644. PubMed ID: 15298838
    [No Abstract]   [Full Text] [Related]  

  • 4. How to optimize participant retention and complete follow-up in surgical research.
    Kaur M; Sprague S; Ignacy T; Thoma A; Bhandari M; Farrokhyar F
    Can J Surg; 2014 Dec; 57(6):420-7. PubMed ID: 25421086
    [No Abstract]   [Full Text] [Related]  

  • 5. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 6. Design and analysis of controlled clinical trials in rheumatic diseases.
    Williams HJ; Reading JC; Ward JR
    Clin Rheum Dis; 1983 Dec; 9(3):499-514. PubMed ID: 6606530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
    Salim A; Mackinnon A; Griffiths K
    Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method to reduce loss to follow-up in clinical trials: informed, withdrawal of consent.
    Cleland JG; Torp-Pedersen C; Coletta AP; Lammiman MJ
    Eur J Heart Fail; 2004 Jan; 6(1):1-2. PubMed ID: 15012911
    [No Abstract]   [Full Text] [Related]  

  • 9. Dropout by design: advance planning for research participant noncompliance.
    Schonfeld T; Anderson J
    Am J Bioeth; 2011 Apr; 11(4):18-20. PubMed ID: 21480067
    [No Abstract]   [Full Text] [Related]  

  • 10. First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives.
    Arch JJ; Craske MG
    Psychiatr Clin North Am; 2009 Sep; 32(3):525-47. PubMed ID: 19716989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sample size estimation for non-inferiority trials of time-to-event data.
    Crisp A; Curtis P
    Pharm Stat; 2008; 7(4):236-44. PubMed ID: 17583558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing missing data in clinical trials.
    van der Laan M; Lorenz TJ
    Ann Intern Med; 2011 Jul; 155(2):135. PubMed ID: 21768593
    [No Abstract]   [Full Text] [Related]  

  • 13. Exploring the use of the sham design for interventional trials: implications for endoscopic research.
    Wilcox CM
    Gastrointest Endosc; 2008 Jan; 67(1):123-7. PubMed ID: 18155434
    [No Abstract]   [Full Text] [Related]  

  • 14. Large trials, small gains: is change on the way?
    Tuma RS
    J Natl Cancer Inst; 2010 Aug; 102(16):1216-17, 1223. PubMed ID: 20693460
    [No Abstract]   [Full Text] [Related]  

  • 15. Is intent-to-treat analysis always (ever) enough?
    Sheiner LB
    Br J Clin Pharmacol; 2002 Aug; 54(2):203-11. PubMed ID: 12207643
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative studies of the effectiveness of therapy].
    Gibiński K
    Pol Tyg Lek; 1987 Jan; 42(1):15-9. PubMed ID: 3588388
    [No Abstract]   [Full Text] [Related]  

  • 17. A framework for planning and critiquing medication compliance and persistence research using prospective study designs.
    Gwadry-Sridhar FH; Manias E; Zhang Y; Roy A; Yu-Isenberg K; Hughes DA; Nichol MB
    Clin Ther; 2009 Feb; 31(2):421-35. PubMed ID: 19302915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What happened to the ones who dropped out? Outcome in eating disorder patients who complete or prematurely terminate treatment.
    Björk T; Björck C; Clinton D; Sohlberg S; Norring C
    Eur Eat Disord Rev; 2009 Mar; 17(2):109-19. PubMed ID: 19142975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines and consensus statements regarding the conduction and reporting of clinical research studies.
    Falagas ME; Pitsouni EI
    Arch Intern Med; 2007 May; 167(9):877-8. PubMed ID: 17502527
    [No Abstract]   [Full Text] [Related]  

  • 20. Motivational change in an inpatient anorexia nervosa population and implications for treatment.
    Wade TD; Frayne A; Edwards SA; Robertson T; Gilchrist P
    Aust N Z J Psychiatry; 2009 Mar; 43(3):235-43. PubMed ID: 19221912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.